Cm. Jabs et al., PLASMA-LEVELS OF HIGH-ENERGY COMPOUNDS COMPARED WITH SEVERITY OF ILLNESS IN CRITICALLY ILL PATIENTS IN THE INTENSIVE-CARE UNIT, Surgery, 124(1), 1998, pp. 65-72
Background. Plasma metabolic changes have been shown to reflect deteri
oration of the energy state of tissue in studies in animals. This stud
y evaluates whether high-energy compounds and their metabolites in pla
sma reflect the clinical condition and predict outcome in critically i
ll patients. Methods. Thirteen critically ill patients with major trau
ma, severe septic shock, or cardiogenic shock (initial Acute Physiolog
y and Chronic Health Evaluation [APACHE] II score greater than or equa
l to 16) were studied. The APACHE II score was recorded daily until di
scharge from the intensive care unit or death. The plasma contents of
adenosine triphosphate, adenosine diphosphate, adenosine, inosine, hyp
oxanthine, creatine phosphate, creatine, uric acid, and lactic acid we
re determined daily. Fifteen healthy volunteers were used as control s
ubjects. Results. All patients with an APACHE II score of 12 or less a
t some time during their stay in the intensive care unit survived (n =
4); all patients with a score of 26 or higher died (n = 5). The initi
al APACHE II median score for survivors was 21 (range 16 to 25; n = 7)
and for nonsurvivors 24 (range 17 to 28; n = 6) (difference not signi
ficant). The final APACHE II score for the survivors was 11 (range 3 t
o 16) and for nonsurvivors 29 (range 20 to 47) (p < 0.01). The plasma
metabolites were grouped according to the patients' APACHE II score of
the day. There was a positive correlation between the severity of met
abolic derangement and the APACHE II score. The plasma contents of ade
nosine triphosphate and creatine phosphate were depleted with higher A
PACHE II scores (p < 0. 01), whereas creatine and uric acid levels inc
reased progressively (p < 0.001). The levels of adenosine, inosine, hy
poxanthine, and lactic acid were elevated significantly in critically
ill patients. Conclusions. Grouping patients with successively higher
APACHE II scores revealed specific patterns of altered plasma metaboli
sm, possibly reflecting different levels of tissue adenylate energy ch
arge. However, neither the initial individual APACHE IT score nor any
initial plasma metabolic level had any prognostic value in this group
of critically ill patients, although the deterioration of the physiolo
gic parameters was coexistent with specific metabolic changes.